Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: Other
Life Threatening? No
Write-up: This case was reported by a physician and described the occurrence of intussusception in a 11-month-old female subject who was vaccinated with ROTARIX (GlaxoSmithKline). Previous and/or concurrent vaccination included DTaP-IPV-HIB; manufacturer unspecified; intramuscular given on 22 October 2007, 14 December 2007 and 18 February 2008; Hep B; manufacturer unspecified; intramuscular given on 15 August 2007, 22 October 2007 and 18 February 2008; Flu; manufacturer unspecified; intramuscular given on 18 February 2008; ROTARIX; GlaxoSmithKline; oral given on 22 October 2007; pneumococcal vaccine, unspecified; manufacturer unspecified; intramuscular given on 22 October 2007 and 14 December 2007; tuberculosis vaccine; non-GSK manufacturer; intradermal given on 15 August 2007. On 14 December 2007 the subject received 2nd dose of ROTARIX (oral). On April 2008, 3 months after vaccination with ROTARIX, the subject was brought to the emergency room due to 4 days of evolution with abundant vomiting, intolerance to oral intake, non assess fever and 2 days of evolution of bloody stools (like black currant jelly). The subject was treated with albendazole, BUTILHIOSCINE. After being admitted to the emergency room with moderate dehydration the subject was diagnosed with intestinal intussusception. Relevant test results included abdominal x-ray which showed fluid levels and dilated bowel loops. On 05 April 2008 the subject underwent a surgery in which intussusception ileocecal and ileoleal was found, in the last portion of the ileo it was found 5 cm of necrosis and later other 10 cm. Therefore a resection was performed for the last portion of ileus, cecal and xyphoid. Ileostomy was done with out complications. The subject presented favorable evolution but required jugular venodissection and packed red blood cell due to anemia. On 06 May 2008 the subject was discharged. The subject was hospitalized and the physician considered the events were clinically significant (or requiring intervention). At the time of reporting the events were resolved. The physician considered the events were unrelated to vaccination with ROTARIX.
Copyright © 2018 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166